Skip to main content Accessibility help
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 1
  • Print publication year: 2016
  • Online publication date: April 2016

Chapter 8 - Congenital heart disease in the fetus

from Section 3 - Fetal anomalies

Related content

Powered by UNSILO
1.Carvalho, JS, Allan, LD, Chaoui, R, et al. ISUOG Practice Guidelines (updated): sonographic screening examination of the fetal heart. Ultrasound Obstet Gynecol 2013; 41: 348–59.
2.The American Institute of Ultrasound in Medicine. AIUM practice guideline for the performance of fetal echocardiography. J Ultrasound Med 2011; 30: 12736.
3.Cardiac screening examination of the fetus: guidelines for performing the ‘basic’ and extended basic’ cardiac scan. Ultrasound Obstet Gynecol 2006; 27(1): 107–13.
4.Yagel, S, Cohen, SM, Achiron, R. Examination of the fetal heart by five short axis views: a proposed screening method for comprehensive cardiac evaluation. Ultrasound Obstet Gynecol 2001; 17(5): 367–9.
5.Rychik, J, Ayres, N, Cuneo, B, et al. American Society of Echocardiography guidelines and standards for performance of the fetal echocardiogram. J Am Soc Echocardiogr 2004; 17: 803–10.
6.Vergani, P, Mariani, S, Ghidini, A, et al. Screening for congenital heart disease with the four chamber view of the fetal heart. Am J Obstet Gynecol 1992; 167: 1000–3.
7.Buskens, E, Grobbee, DE, Frohn-Mulder, IM, et al. Efficacy of routine fetal ultrasound screening for congenital heart disease in normal pregnancy. Circulation 1996; 94: 6772.
8.Copel, JA, Pilu, G, Green, J, et al. Fetal echocardiographic screening for congenital heart disease: The importance of the four-chamber view. Am J Obstet Gynecol 1987; 157: 648.
9.Oggè, G, Gaglioti, P, Maccanti, S, et al. Prenatal screening for congenital heart disease with four-chamber and outflow-tract views: A multicenter study. Ultrasound Obstet Gynecol 2006; 28: 779.
10.Chaoui, R. The four-chamber view: four reasons why it seems to fail in screening for cardiac abnormalities and suggestions to improve detection rates. Ultrasound Obstet Gynecol 2003; 22: 3.
11.DeVore, GR. The aortic and pulmonary outflow tract screening in the human fetus. J Ultrasound Med 1992; 11: 345.
12.Carvalho, JS, Mavrides, E, Shinebourne, E, et al. Improving the effectiveness of routine prenatal screening for major congenital heart defects. Heart 2002; 88: 387.
13.Kirk, JS, Riggs, TW, Comstock, CH, et al. Prenatal screening for cardiac anomalies: The value of routine addition of the aortic root to the four chamber view. Obstet Gynecol 1994; 84: 427.
14.Allan, L, Hornberger, L, Sharland, G (eds). Textbook of Fetal Cardiology. London: Greenwich Medical Media, 2000.
15.Yagel, S, Silverman, N, Gembruch, U (eds). Fetal Cardiology. London: Martin Dunitz, 2003.
16.Schneider, C, McCrindle, BW, Carvalho, JS, et al. Development of Z-scores for fetal cardiac dimensions from echocardiography. Ultrasound Obstet Gynecol 2005; 26: 599.
17.DeVore, G. The use of Z-scores in the analysis of fetal cardiac dimensions. Ultrasound Obstet Gynecol 2005; 26: 596.
18.Firpo, C, Hoffman, J, Silverman, N. Evaluation of fetal heart dimensions from 12 weeks to term. Am J Cardiol 2001; 87: 594.
19.Khoshnood, B, De Vigan, C, Vodovar, V, et al. Trends in prenatal diagnosis, pregnancy termination, and perinatal mortality of newborns with congenital heart disease in France, 1983–2000: a population-based evaluation. Pediatrics 2005; 115: 95.
20.Hoffman, JI, Kaplan, S. The incidence of congenital heart disease. J. Am. Coll. Cardiol 2002; 39: 18901900.
21.Ferencz, C, Rubin, JD, McCarter, RJ, et al. Congenital heart disease: Prevalence at live birth. The Baltimore-Washington Infant Study. Am J Epidemiol 1985; 121: 31.
22.Garne, E, Stoll, C, Clementi, M; Euroscan Group. Evaluation of prenatal diagnosis of congenital heart diseases by ultrasound: experience from 20 European registries. Ultrasound Obstet Gynecol 2001; 17: 386.
23.Ariane, J, Marelli, AS, Mackie, RII, et al. Congenital heart disease in the general population changing prevalence and age distribution. Circulation 2007; 115: 163172.
24.van der Linde, D, Konings, EE, Slager, MA, et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol 2011; 58(21): 2241–7.
25.Hoffman, J, Christianson, R. Congenital heart disease in a cohort of 19,502 births with long-term follow-up. Am J Cardiol 1978; 42: 641.
26.Allen, H, Gutgesell, H, Clark, E, et al. (eds). Moss and Adams’ Heart Disease in Infants, Children and Adolescents Including the Fetus and Young Adult, 6th ed. Philadelphia: Lippincott Williams & Wilkins, 2001.
27.Keane, J, Lock, J, Fyler, D, et al. (eds). Nadas’ Pediatric Cardiology, 2nd edn. Philadelphia: Saunders, 2006.
28.Rajiah, P, Mak, C, Dubinksy, TJ, et al. Ultrasound of fetal cardiac anomalies. AJR Am J Roentgenol 2011; 197(4): W74760.
29.Burch, M. Congenital heart disease. Medicine 2006; 34; 7: 274281.
30.Jaeggi, ET, Sholler, GF, Jones, OD, et al. Comparative analysis of pattern, management and outcome or pre versus postnatally diagnosed major congenital heart disease: A population-based study. Ultrasound Obstet Gynecol 2001; 17: 380.
31.Kirklin, JW, Barratt-Boyes, BG. Cardiac Surgery, 2nd edn. New York: Churchill Livingstone, 1993.
32.Anderson, RH, Macartney, FJ, Shinebourne, EA, et al. Paediatric Cardiology. Edinburgh: Churchill Livingstone, 2001.
33.Uzun, O Ethical dilemmas in Fetal Cardiology: improving outcomes or reducing incidence. Welsh Paed J 2008; 24: 2225.
34.Gopalakrishnan, PN, Sinha, A, Uzun, O. Change in referral and diagnostic trends in fetal cardiac screening over 7 years in South Wales. Arch Dis Child Fetal Neonatal Ed 2011; 96: Fa66Fa67.
35.Sinha, A, Gopalakrishnan, PN, Tucker, D, et al. Outcome after prenatal diagnosis of hypoplastic left heart syndrome (HLHS) in South Wales over a 7-year period. Arch Dis Child Fetal Neonatal Ed 2011; 96: Fa67.
36.Sinha, A, Gopalakrishnan, PN, Tucker, D, et al. Outcome of all antenatally diagnosed cases of complete atrioventricular septal defect (CAVSD) in South Wales over a 7 year period: impact of associated chromosomal anomalies. Arch Dis Child Fetal Neonatal Ed 2011; 96: Fa69.
37.Uzun, O, Sinha, A. Outcome of hypoplastic left and right heart syndrome (HLHS and HRHS) after antenatal diagnosis in South Wales over a seven year period. Cardiol Young 2011; 21 (Suppl. 1): S1S167.
38.Uzun, O. Outcome of congenital heart defects associated with 22q11.2 Deletion. AEPC 2012, Istanbul. Cardiol Young 2012; 22 (Suppl. S1): S3S176.
39.Uzun, O, Ofoe, V, Worrall, S. Changing trends in tetralogy of Fallot: impact of improved antenatal detection rate, earlier catheter and surgical intervention. Cardiol Young 2014; 24 (Suppl. 1): S148.
40.Uzun, O, Babaoglu, K, Bendapudi, P, et al. Total anomalous pulmonary venous connection: clinical presentation and long term outcome of 60 patients at a single institution in 32 years. AEPC 2014 Helsinki. Cardiol Young 2014; 24 (Suppl. 1): S6061.
41.Pierpont, ME, Craig, T, Basson, D. Genetic basis for congenital heart defects: current knowledge. A scientific statement from the American Heart Association Congenital Cardiac Defects Committee Council on Cardiovascular Disease in the Young. Circulation 2007; 115: 301538.
42.Peter, J, Gruber, PJ, Epstein, JA. Development gone awry: congenital heart Disease. Circ Res 2004; 94: 27383.
43.Kyle Niessen, K, Karsan, A. Notch signaling in cardiac development. Circ Res 2008; 102: 116981.
44.Stankunas, K, Shang, C, Twu, KY, et al. Pbx/Meis deficiencies demonstrate multigenetic origins of congenital heart disease. Circ Res 2008; 103: 7029.
45.James, J, Noba, JJ. Multifactorial inheritance hypothesis for the etiology of congenital heart diseases: the genetic-environmental interaction. Circulation 1968; 38: 60417.
46.Goldmuntz, E. The genetic contribution to congenital heart disease. Pediatr Clin N Am 2004; 51: 1721–37.
47.Marino, B, Digilio, MC. Congenital heart disease and genetic syndromes: Specific correlation between cardiac phenotype and genotype. Cardiovasc Pathol 2000; 9: 30315.
48.Nora, JJ, Nora, AH. Maternal transmission of congenital heart diseases: new recurrence risk figures and the questions of cytoplasmic inheritance and vulnerability to teratogens. Am J Cardiol 1987; 59: 459.
49.Allan, LD, Crawford, DC, Chita, SK, et al. Familial recurrence of congenital heart disease in a prospective series of mothers referred for fetal echocardiography. Am J Cardiol 1986; 58: 334.
50.Boughman, JA, Berg, KA, Astemborski, JA, et al. Familial risks of congenital heart defect in a population-based epidemiological study. Am J Med Genet 1987; 26: 839.
51.Whittemore, R, Wells, J, Castellsague, X. A second-generation study of 427 probands with congenital heart defects and their 837 children. J Am Coll Cardiol 1994; 23: 1459.
52.Hyett, J, Perdu, M, Sharland, G, et al. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10–14 weeks of gestation: population based cohort study. BMJ 1999; 318: 81.
53.Burn, J, Brennan, P, Little, J, et al: Recurrence risks in offspring of adults with major heart defects: Results from first cohort of British collaborative study. Lancet 1998; 351: 311.
54.Garne, E, Stoll, C, Clementi, M; Euroscan Group. Evaluation of prenatal diagnosis of congenital heart diseases by ultrasound: experience from 20 European registries. Ultrasound Obstet Gynecol 2001; 17: 386.
55.Copel, JA, Pilu, G, Kleinman, CS. Congenital heart disease and extracardiac anomalies: Associations and indications for fetal echocardiography. Am J Obstet Gynecol 1986; 154: 1121.
56.Kleinman, C, Nehgme, R, Copel, J. Fetal cardiac arrhythmias: diagnosis and therapy. In: Creasy, R, Resnik, R, Iams, J (eds). Maternal-Fetal Medicine, 5th edn. Philadelphia: Saunders, 2003.
57.Kleinman, CS, Nehgme, RA. Cardiac arrhythmias in the human fetus. Pediatr Cardiol 2004; 25: 234.
58.Simpson, J. Fetal arrhythmias. Ultrasound Obstet Gynecol 2006; 27: 599.
59.Respondek, M, Wloch, A, Kaczmarek, P, et al. Diagnostic and perinatal management of fetal extrasystole. Pediatr Cardiol 1997; 18: 361.
60.Strasburger, J, Huhta, J, Carpenter, R, et al. Doppler echocardiography in the diagnosis and management of persistent fetal arrhythmias. J Am Coll Cardiol 1986; 7: 1386.
61.Uzun, O, Sinha, A, Beattie, B. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: Results of a nonrandomized multicenter study. Circulation 2012; 125: e956.
62.Uzun, O, Babaoglu, K, Sinha, A, et al. Rapid control of foetal supraventricular tachycardia with digoxin and flecainide combination treatment. Cardiol Young 2011; 29: 19.
63.Uzun, O, Babaoglu, K, Ayhan, YI, et al. Maternal serum antiarrhythmic drug levels do not predict fetal supraventricular tachycardia response time. AEPC 2013, London. Cardiol Young 2013; 23 (Suppl. 1): S57.
64.Babaoglu, K, Uzun, O, Ayhan, YI, et al. 10-year review of outcome of fetal arrhythmias in Wales. AEPC 2012, Istanbul. Cardiol Young 2012; 22 (Suppl. S1): S3S176.
65.Uzun, O. Outcome of heart block diagnosed during fetal and postnatal life. AEPC 2012, Istanbul. Cardiol Young 2012; 22 (Suppl. S1): S3S176.
66.Donofrio, MT, Moon-Grady, AJ, Hornberger, LK, et al; American Heart Association Adults with Congenital Heart Disease Joint Committee of the Council on Cardiovascular Disease in the Young and Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Council on Cardiovascular and Stroke Nursing. Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association. Circulation 2014; 129(21): 2183–242.